Cargando…

Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients

The mechanisms underlying hepatic inflammation and fibrogenesis in chronic hepatitis B (CHB) are complex and several cytokines are involved. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a member of the tumor necrosis factor superfamily which also acts as a cytokine. This study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asil, Mehmet, Dertli, Ramazan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402569/ https://www.ncbi.nlm.nih.gov/pubmed/27631226 http://dx.doi.org/10.1097/MD.0000000000004763

Ejemplares similares

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
por: Oztas, Erkin, et al.
Publicado: (2015)

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Vitamin D serum level is associated with Child–Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients
por: Zhao, Xin-yan, et al.
Publicado: (2016)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients
por: Wang, Weixia, et al.
Publicado: (2016)

Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment
por: Yang, Jiezuan, et al.
Publicado: (2017)

Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
por: Wang, Lingmei, et al.
Publicado: (2020)

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015)

Expression and significance of urinary microRNA in patients with chronic hepatitis B
por: Shang, Jia-Wei, et al.
Publicado: (2019)

Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B
por: Sun, Yan-Yan, et al.
Publicado: (2015)

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks: A retrospective observational study
por: Zhang, Yafei, et al.
Publicado: (2019)

Weifuchun alters tongue flora and decreases serum trefoil factor I levels in gastric intestinal metaplasia: A CONSORT-compliant article
por: Hua, Zhaolai, et al.
Publicado: (2022)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

A novel system for predicting liver histopathology in patients with chronic hepatitis B
por: Pan, An-Na, et al.
Publicado: (2017)

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B
por: Liu, Liang, et al.
Publicado: (2019)

The Plasma S-adenosylmethionine Level is Associated With the Severity of Hepatitis B-Related Liver Disease
por: Li, Ting, et al.
Publicado: (2015)

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
por: Maarouf, Adil, et al.
Publicado: (2019)

Red Blood Cell Distribution Width Levels Correlate With Liver Fibrosis and Inflammation: A Noninvasive Serum Marker Panel to Predict the Severity of Fibrosis and Inflammation in Patients With Hepatitis B
por: Xu, Wen-Shen, et al.
Publicado: (2015)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B: An observational study
por: Chen, Yi-Cheng, et al.
Publicado: (2022)

Efficacy and safety of vesatolimod in chronic hepatitis B: A systematic review and meta-analysis
por: Omer, Ibrahim, et al.
Publicado: (2023)

Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis
por: Chen, Zhi-Xian, et al.
Publicado: (2015)

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
por: Tsai, Pei-Chien, et al.
Publicado: (2017)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C
por: Chen, Sheng-Hung, et al.
Publicado: (2016)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
por: Lee, Dohyeong, et al.
Publicado: (2019)

Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021)

Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients
por: Zhou, Pu, et al.
Publicado: (2015)

Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study
por: Irham, Lalu Muhammad, et al.
Publicado: (2019)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
por: Liu, Yanqiong, et al.
Publicado: (2015)

Preserved Function of Circulating Invariant Natural Killer T Cells in Patients With Chronic Hepatitis B Virus Infection
por: Zhu, Haoxiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8rs1tbv0hi0srgfk3mscmhmn56